PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.
暂无分享,去创建一个
M. Matsuda | S. Kihara | T. Funahashi | Y. Matsuzawa | I. Shimomura | T. Nakamura | H. Kuriyama | K. Hotta | K. Kishida | H. Nishizawa | N. Maeda | N. Ouchi | M. Takahashi | R. Komuro | H. Nagaretani | Tadashi Nakamura | Masahiko Takahashi
[1] T. Funahashi,et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.
[2] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[3] NoriyukiOuchi,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001 .
[4] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[6] J. Weber,et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Kihara,et al. Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-&kgr;B Signaling Through a cAMP-Dependent Pathway , 2000, Circulation.
[8] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[9] J. Olefsky. Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists , 2000 .
[10] J. Flier,et al. Obesity and insulin resistance. , 2000, The Journal of clinical investigation.
[11] S. Kihara,et al. Genomic structure and mutations in adipose-specific gene, adiponectin , 2000, International Journal of Obesity.
[12] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[13] T Nakamura,et al. An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[14] E. Ravussin,et al. Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of Humans With Type 2 Diabetes , 2000, International journal of experimental diabetes research.
[15] NoriyukiOuchi,et al. Novel Modulator for Endothelial Adhesion Molecules , 1999 .
[16] R. Ross. Atherosclerosis is an inflammatory disease , 1999 .
[17] T. Funahashi,et al. Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines · Adipocyte‐derived Bioactive Substances , 1999, Annals of the New York Academy of Sciences.
[18] J. Auwerx,et al. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator. , 1999, Annals of medicine.
[19] R. Hammer,et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy , 1999, Nature.
[20] T. Willson,et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase , 1999, Nature.
[21] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[22] S. Kihara,et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. , 1999, Internal medicine.
[23] T. Willson,et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. , 1999, Nature.
[24] T. Langmann,et al. Identification and characterization of the human adipocyte apM-1 promoter. , 1998, Biochimica et biophysica acta.
[25] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[26] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[27] K. Umesono,et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. , 1998, The Journal of clinical investigation.
[28] Philipp E. Scherer,et al. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.
[29] B. Seed,et al. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines , 1998, Nature.
[30] B. Seed,et al. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. , 1998, Nature.
[31] M. Jensen,et al. Obesity and cardiovascular disease: is body structure a factor? , 1997, Current opinion in lipidology.
[32] Y. Matsuzawa,et al. Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.
[33] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[34] J. Auwerx,et al. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. , 1996, The Journal of clinical investigation.
[35] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[36] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[37] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[38] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[39] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[40] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[41] B. Spiegelman,et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. , 1994, Endocrinology.
[42] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[43] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[44] J. Flier,et al. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. , 1992, Hypertension.